CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 and ...
Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...
Air Voel, a fast-growing Canadian provider of sleep therapy and respiratory care equipment, has announced the expansion of its nationwide distribution network for the highly in-demand ResMed AirSense ...
The big unknown in the sleep apnea world continues to be when Philips will re-enter the market. ResMed has more than risen to the challenge of meeting unprecedented demand in the competitor's absence, ...
We maintain our USD 258 fair value estimate for narrow-moat ResMed RMD, or AUD 40 per CDI at current exchange rates, following first-quarter fiscal 2024 results. Underlying EBIT of USD 319 million ...
ResMed, Inc. RMD recently introduced its AirCurve 11 series devices -- the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory ...
Amid a recall of its AirFit and AirTouch continuous positive airflow pressure (CPAP) devices, ResMed released its latest earnings report Wednesday afternoon. The San Diego-based medical device company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results